Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Treatment varies by cancer stage; early-stage often involves surgery and chemotherapy, while advanced stages may use immunotherapy. Risk factors differ between squamous cell cancer and adenocarcinoma, ...

Notably, approximately 63% of these patients had centrally located squamous cell carcinoma, reflecting real-world patient demographics. Ivonescimab combined with chemotherapy exhibited superior PFS ...

gil.com.au Aim: To review the clinical features, management, and outcomes of surgical treatment of eyelid squamous cell carcinoma (SCC). Methods: A retrospective review of all eyelid SCCs treated ...

Reasonably, authors should adapt the title and the abstract in a way that it recapitulates the whole data, which is HOXA1/RNUX2/PRDX2 axis control of cell death, including ferroptosis and apoptosis in ...

In previously published work, the authors found that Transforming Growth Factor β Activated Kinase 1 (TAK1) may regulate esophageal squamous cell carcinoma (ESCC) tumor cell proliferation via the ...